Top 30 Companies Global Advanced Oral Drug Delivery Market in (2025-2033)

The Global Advanced Oral Drug Delivery Market is valued at USD 42.2 Billion in 2025 and is projected to reach USD 75.9 Billion by 2033, growing at a CAGR of 7.6%. This market encompasses a range of technologies and formulations that facilitate the effective delivery of medications through oral administration. Key factors driving growth include the increasing demand for patient-friendly drug delivery systems, the expansion of biopharmaceuticals, and advancements in drug formulation technologies.

Technological innovations in drug delivery, such as the development of novel oral solid dosage forms, are contributing to the market's expansion. Additionally, the rise in chronic diseases and the growing prevalence of geriatric populations highlight the need for advanced oral drug delivery solutions.

Global Advanced Oral Drug Delivery Market Size, Data, & Statistics

The Global Advanced Oral Drug Delivery Market reached a size of USD 31.9 Billion in 2021. It grew to USD 34 Billion in 2022, further increasing to USD 36.7 Billion in 2023. The market is forecasted to continue expanding, reaching USD 39.1 Billion in 2024 and USD 42.2 Billion in 2025.

By 2033, the market is projected to achieve a value of USD 75.9 Billion, reflecting significant growth throughout the period. The CAGR for the market from 2025 to 2033 is estimated at 7.6%. This sustained growth highlights the increasing adoption of advanced oral drug delivery methods.

Regionally, the market distribution is as follows: North America holds a share of 38.8%, Europe accounts for 27.8%, Asia Pacific captures 23.4%, while South America and the Middle East and Africa each represent 5% of the market.

Top 10 Trends in the Global Advanced Oral Drug Delivery Market

Smart drug delivery systems integrate with digital health

Advancements in digital health technologies enable the development of smart drug delivery systems that can monitor patient adherence and enhance therapeutic outcomes. These systems utilize mobile applications and wearable devices, ensuring real-time data collection and patient engagement.

Biologics drive the need for advanced formulations

The increasing use of biologics necessitates sophisticated oral drug delivery formulations that improve bioavailability and therapeutic efficacy. Companies focus on developing encapsulation technologies and oral delivery systems that cater to the unique requirements of biologic drugs.

Focus on patient-centric drug delivery systems

There is a heightened emphasis on creating patient-centric drug delivery systems that address patient needs for convenience and compliance. This shift is prompting innovations in oral dosage forms, including fast-dissolving tablets and personalized medication regimens.

Expansion of nanotechnology in drug formulation

Nanotechnology is increasingly employed in drug formulation to enhance solubility and bioavailability of poorly soluble drugs. This trend supports the development of advanced oral drug delivery systems that optimize therapeutic performance.

Sustainability drives packaging innovations

Environmental sustainability is gaining traction in the pharmaceutical industry, leading to innovations in eco-friendly packaging solutions for oral drug delivery systems. Companies are exploring biodegradable materials and recyclable designs to reduce environmental impact.

Regulatory advancements support market growth

Streamlined regulatory processes for novel drug delivery systems are facilitating faster approvals and market entry. This trend encourages research and development investments in advanced oral drug delivery technologies.

Collaboration between pharmaceutical companies and tech firms

Collaborative efforts between pharmaceutical companies and technology firms are fostering innovation in advanced oral drug delivery. These partnerships leverage expertise in drug development and digital health to enhance product offerings.

Rise of digital therapeutics

The integration of digital therapeutics with oral drug delivery systems is on the rise. This trend promotes comprehensive treatment approaches that combine medication with behavioral and lifestyle interventions for better health outcomes.

Increased focus on targeted delivery mechanisms

Targeted delivery mechanisms are being developed to enhance the precision of drug action while minimizing side effects. This approach is particularly relevant for treatments addressing chronic diseases, where localized therapy is needed.

Growth in emerging markets

Emerging markets present significant growth opportunities for advanced oral drug delivery. Increasing healthcare access, rising disposable incomes, and growing awareness of advanced therapeutic options are driving demand in these regions.

Top 30 Companies in the Global Advanced Oral Drug Delivery Market

1. Veltio Pharma AB

Founded: 2014

Veltio Pharma AB specializes in developing innovative oral drug delivery systems. The company focuses on enhancing the bioavailability and therapeutic efficacy of its pharmaceutical products. Veltio Pharma is known for its commitment to research and development, leveraging advanced technologies to deliver high-quality drug formulations tailored to meet patient needs.

2. Catalent, Inc.

Founded: 2007

Catalent, Inc. offers a wide range of advanced oral drug delivery solutions. Known for its robust contract development and manufacturing services, the company supports pharmaceutical and biopharmaceutical clients in creating innovative dosage forms. Catalent's expertise in formulation science enables the efficient development of complex drug products that enhance patient experiences.

3. Lonza Group Ltd.

Founded: 1897

Lonza Group Ltd. is a global leader in life sciences and specializes in advanced oral drug delivery technologies. The company provides comprehensive solutions that include drug formulation and development services. Lonza's innovative approaches are aimed at improving the bioavailability and performance of oral medications, addressing critical patient needs.

4. Evonik Industries AG

Founded: 2003

Evonik Industries AG develops high-performance materials for advanced drug delivery applications. The company emphasizes innovative formulation technology that optimizes drug absorption and efficacy. Evonik’s commitment to sustainability and efficiency drives its development of tailored solutions for the pharmaceutical industry.

5. BASF SE

Founded: 1865

BASF SE is a major global player in the chemical industry, providing advanced solutions for oral drug delivery. The company focuses on polymer-based drug delivery systems that enhance the stability and bioavailability of pharmaceutical products. BASF’s strong focus on innovation enables it to meet the diverse needs of the drug delivery market.

6. Ashland Inc.

Founded: 1924

Ashland Inc. delivers solutions for drug formulation and delivery, specializing in cellulose-based technologies. The company offers a range of excipients and delivery systems designed to optimize oral medication performance. Ashland's commitment to research and development positions it as a key partner in the advanced oral drug delivery sector.

7. Roquette Frères

Founded: 1933

Roquette Frères is dedicated to providing solutions for the pharmaceutical industry, focusing on advanced oral drug delivery systems. The company offers a variety of excipients and formulation technologies that enhance drug solubility and efficacy. Roquette's innovation and expertise in polysaccharides make it a vital contributor to drug development.

8. Colorcon, Inc.

Founded: 1961

Colorcon, Inc. specializes in developing excipients and systems for oral drug delivery. The company's solutions are designed to enhance the performance of pharmaceuticals, focusing on film coating and modified-release technologies. Colorcon is known for its commitment to quality and regulatory compliance, ensuring that its products meet industry standards.

9. Croda International Plc

Founded: 1925

Croda International Plc provides high-performance ingredients and solutions for advanced drug delivery. The company emphasizes innovation in formulation technologies that improve drug bioavailability and stability. Croda’s dedication to sustainable practices reinforces its position as a trusted partner in the pharmaceutical sector.

10. Gattefossé SAS

Founded: 1880

Gattefossé SAS specializes in the development of excipients for the pharmaceutical industry, focusing on advanced oral drug delivery systems. The company's portfolio includes a range of solutions aimed at enhancing drug formulation and patient compliance. Gattefossé's commitment to innovation drives its development of advanced drug delivery technologies.

11. ABITEC Corporation

Founded: 1984

ABITEC Corporation provides advanced drug delivery solutions, specializing in lipid-based formulations. The company focuses on enhancing the solubility and stability of pharmaceuticals through innovative delivery systems. ABITEC's expertise in lipid chemistry positions it as a key player in the advanced oral drug delivery market.

12. The Lubrizol Corporation

Founded: 1928

The Lubrizol Corporation develops advanced drug delivery technologies, focusing on polymer-based solutions. The company's products enhance the efficacy and stability of oral medications, catering to the needs of pharmaceutical manufacturers. Lubrizol's commitment to innovation and quality supports its role in the oral drug delivery sector.

13. Merck KGaA / MilliporeSigma

Founded: 1668

Merck KGaA, through its MilliporeSigma division, offers a range of advanced drug delivery solutions. The company focuses on providing high-quality excipients and formulation services that enhance drug performance. Merck KGaA's extensive experience in the pharmaceutical industry positions it as a trusted partner for drug development.

14. Shin-Etsu Chemical Co., Ltd.

Founded: 1926

Shin-Etsu Chemical Co., Ltd. specializes in developing high-performance materials for the pharmaceutical industry. The company offers advanced solutions for oral drug delivery, focusing on improving drug solubility and stability. Shin-Etsu's commitment to research and innovation drives its advancements in drug delivery technologies.

15. SPI Pharma

Founded: 1943

SPI Pharma develops innovative excipients and delivery systems for oral drug formulations. The company focuses on enhancing the performance of pharmaceuticals through specialized solutions. SPI Pharma's strong emphasis on quality and customer collaboration supports its reputation in the advanced oral drug delivery market.

16. DFE Pharma

Founded: 2001

DFE Pharma specializes in developing excipients for the pharmaceutical industry, focusing on oral drug delivery applications. The company's innovative products enhance drug solubility and bioavailability. DFE Pharma's commitment to quality and customer service has established it as a reliable partner in the advanced oral drug delivery sector.

17. Thermo Fisher Scientific / Patheon

Founded: 2006

Thermo Fisher Scientific, through its Patheon division, offers comprehensive solutions for oral drug delivery. The company specializes in formulation development and manufacturing services that cater to the needs of pharmaceutical clients. Thermo Fisher's focus on innovation and quality positions it as a leader in the advanced oral drug delivery market.

18. Aenova Group GmbH

Founded: 2014

Aenova Group GmbH provides contract manufacturing and development services for advanced oral drug delivery systems. The company focuses on delivering high-quality pharmaceutical products that meet stringent regulatory requirements. Aenova's commitment to innovation enhances its position in the advanced oral drug delivery market.

19. Hovione

Founded: 1959

Hovione specializes in providing advanced oral drug delivery solutions and contract manufacturing services. The company's focus is on developing innovative formulations that enhance drug efficacy and patient compliance. Hovione's extensive experience in pharmaceutical development supports its reputation as a key player in the market.

20. Adare Pharma Solutions

Founded: 2010

Adare Pharma Solutions develops advanced oral drug delivery technologies, specializing in drug formulation and manufacturing. The company focuses on enhancing the stability and bioavailability of pharmaceuticals. Adare's innovative solutions cater to the evolving needs of the pharmaceutical industry.

21. Quotient Sciences

Founded: 1997

Quotient Sciences provides integrated drug development and manufacturing services, focusing on advanced oral drug delivery systems. The company emphasizes collaboration with clients to deliver tailored solutions that meet specific drug formulation needs. Quotient Sciences' comprehensive capabilities enhance its role in the pharmaceutical landscape.

22. AustinPx

Founded: 2017

AustinPx specializes in developing innovative drug delivery systems for the pharmaceutical industry. The company focuses on enhancing the performance of oral medications through advanced formulation technologies. AustinPx's commitment to research and development positions it as a key contributor to the advanced oral drug delivery market.

23. Nanoform Finland Plc

Founded: 2015

Nanoform Finland Plc specializes in nanotechnology for drug delivery applications. The company focuses on enhancing the solubility and bioavailability of pharmaceuticals through innovative nanoparticle engineering. Nanoform's cutting-edge technologies support advancements in the advanced oral drug delivery sector.

24. Aquestive Therapeutics, Inc.

Founded: 2008

Aquestive Therapeutics, Inc. develops advanced oral drug delivery systems with a focus on improving patient compliance. The company emphasizes the development of innovative formulations that enhance the therapeutic effectiveness of medications. Aquestive's commitment to patient-centric solutions positions it as a leader in the oral drug delivery market.

25. LTS Lohmann Therapie-Systeme AG

Founded: 1981

LTS Lohmann Therapie-Systeme AG specializes in developing advanced drug delivery technologies, particularly in oral applications. The company's focus on innovative dosage forms enhances drug performance and patient adherence. LTS's expertise in formulation and development supports its role in the pharmaceutical industry.

26. Aprecia Pharmaceuticals, LLC

Founded: 2003

Aprecia Pharmaceuticals, LLC focuses on advanced oral drug delivery solutions, specifically using 3D printing technology. The company aims to enhance the efficacy and precision of drug formulations. Aprecia’s innovative approach positions it as a pioneer in the advanced oral drug delivery market.

27. Recipharm AB

Founded: 1995

Recipharm AB provides contract development and manufacturing services for advanced oral drug delivery. The company focuses on delivering high-quality pharmaceutical products tailored to meet client specifications. Recipharm's extensive experience in the industry supports its reputation for reliability and quality.

28. Ardena

Founded: 2013

Ardena specializes in drug development and manufacturing services, focusing on advanced oral drug delivery systems. The company emphasizes collaboration with clients to create tailored solutions that meet regulatory requirements. Ardena's commitment to quality ensures its strong position in the pharmaceutical sector.

29. Piramal Pharma Solutions

Founded: 1984

Piramal Pharma Solutions provides integrated solutions for drug development and manufacturing, with a focus on advanced oral drug delivery. The company offers a range of services that enhance drug formulation and delivery. Piramal's commitment to quality and innovation supports its reputation in the industry.

30. CordenPharma

Founded: 2006

CordenPharma specializes in providing contract development and manufacturing services for advanced oral drug delivery systems. The company's focus on quality and regulatory compliance ensures that its products meet industry standards. CordenPharma's dedication to innovation supports its position as a key player in the pharmaceutical landscape.

Conclusion

The Global Advanced Oral Drug Delivery Market is poised for substantial growth, driven by technological advancements and increasing patient demand for effective drug delivery systems. The diverse array of companies presented highlights the industry's focus on innovation and collaboration, ensuring the development of advanced solutions.

As the market evolves, stakeholders in the pharmaceutical sector should consider the capabilities of these Advanced Oral Drug Delivery companies in addressing emerging challenges and opportunities. Engaging with these innovative partners can lead to enhanced drug delivery outcomes and improved patient experiences.